CYDY
Price:
$0.32
Market Cap:
$404.02M
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (COVID-19). It is also conducting a Phase 1b/2 clinical trial with leronlimab in metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.
Industry
Biotechnology
IPO Date
2006-12-13
Stock Exchange
OTC
Ticker
CYDY
According to CytoDyn Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 438.46M. This represents a change of 25.09% compared to the average of 350.51M of the last 4 quarters.
The mean historical Enterprise Value of CytoDyn Inc. over the last ten years is 396.86M. The current 438.46M Enterprise Value has changed 10.95% with respect to the historical average. Over the past ten years (40 quarters), CYDY's Enterprise Value was at its highest in in the February 2021 quarter at 2.56B. The Enterprise Value was at its lowest in in the November 2015 quarter at 69.06M.
Average
396.86M
Median
216.65M
Minimum
82.09M
Maximum
1.25B
Discovering the peaks and valleys of CytoDyn Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.02%
Maximum Annual Enterprise Value = 1.25B
Minimum Annual Increase = -78.71%
Minimum Annual Enterprise Value = 82.09M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 424.07M | 133.64% |
| 2024 | 181.51M | -27.91% |
| 2023 | 251.79M | -4.16% |
| 2022 | 262.71M | -78.71% |
| 2021 | 1.23B | -1.40% |
| 2020 | 1.25B | 1.02% |
| 2019 | 112.00M | 33.46% |
| 2018 | 83.92M | 2.24% |
| 2017 | 82.09M | -3.14% |
| 2016 | 84.75M | 40.92% |
The current Enterprise Value of CytoDyn Inc. (CYDY) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
285.79M
5-year avg
470.83M
10-year avg
396.86M
CytoDyn Inc.’s Enterprise Value is greater than Immutep Limited (316.92M), greater than Cellectis S.A. (381.66M), greater than Clinuvel Pharmaceuticals Limited (394.46M), less than Northwest Biotherapeutics, Inc. (439.79M), less than Healios K.K. (39.39B), greater than Frontage Holdings Corporation (372.36M), greater than Clinuvel Pharmaceuticals Limited (394.46M), greater than Transgene S.A. (135.53M), less than Hansa Biopharma AB (publ) (3.50B), less than BioInvent International AB (publ) (1.43B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 316.92M | $264.95M | |
| 381.66M | $325.46M | |
| 394.46M | $377.94M | |
| 439.79M | $367.30M | |
| 39.39B | $344.26M | |
| 372.36M | $303.75M | |
| 394.46M | $408.89M | |
| 135.53M | $132.89M | |
| 3.50B | $246.65M | |
| 1.43B | $216.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CytoDyn Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CytoDyn Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CytoDyn Inc.'s Enterprise Value?
What is the highest Enterprise Value for CytoDyn Inc. (CYDY)?
What is the 3-year average Enterprise Value for CytoDyn Inc. (CYDY)?
What is the 5-year average Enterprise Value for CytoDyn Inc. (CYDY)?
How does the current Enterprise Value for CytoDyn Inc. (CYDY) compare to its historical average?